Abstract:Introduction: Women with unilateral breast cancer are at increased risk for having simultaneous cancer of the contralateral breast. Overall, earlier detection of contralateral breast cancer prevents the burden of additional surgery or chemotherapy rounds and is associated with higher overall survival. However, MRI screening for the contralateral breast is seldom done following an initial unilateral breast cancer diagnosis. The purpose of this study is to retrospectively evaluate patients with known, biopsy-proven malignancy who went on to obtain a breast MRI and were later found to have cancer of the contralateral breast. Methods: This was a retrospective study that reviewed the charts of women aged over 18 years who were determined to have synchronous bilateral breast cancer from January 2017 to January 2022 at the University of Florida, Gainesville, FL. The study extracted data from this institution's cancer registry database, which provided information on patients with breast cancer diagnoses. The study conducted a review of mammography (MAM) and MRI imaging reports to ascertain the presence or absence of contralateral breast cancer identified by each respective imaging modality. Surgical pathology reports from the biopsy of the contralateral breast were reviewed to obtain information on the histological type of cancer and TNM (tumor, node, metastasis) staging. Results: Of the 17 cases in which MAM missed contralateral cancer, follow-up MRI detected contralateral malignancy in 12 cases (70.59%) and subsequently changed management, resulting in additional imaging, biopsy, and eventual diagnosis and treatment of contralateral breast cancer. Examining the number of contralateral breast cancers detected by patients who had undergone MAM followed by MRI and those who had only undergone MAM, the study found that the detection rate of contralateral breast cancer from MAM was 45.45% (15/33). The tumor stages of the missed cancers were all T1 or Tis stage with one T1mi, and there was no nodal involvement. Conclusion: In addition to its utility in staging breast cancers, MRI also has the superior ability to detect otherwise undetected contralateral breast malignancy. This retrospective study found that MRI imaging led to a considerable increase in the detection of contralateral cancer. The study found that these undetected contralateral breast cancers by MAM were often of lower staging with no nodal involvement, highlighting the opportunity for MRI to assist in early cancer detection while the patient's prognosis is still good. Its high cost should be balanced with staging and occult malignancy detection utility in future practice.

Breast MRI after Mammography Detects Additional Aggressive Cancers, Study Shows.

MRI-only breast cancers are less aggressive than cancers identifiable on conventional imaging

Can Combined Screening of Ultrasound and Elastography Improve Breast Cancer Identification Compared with MRI in Women with Dense Breasts-a Multicenter Prospective Study

MRI for breast cancer screening, diagnosis, and treatment

Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging

Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis

Survival Outcomes of Screening with Breast MRI in Women at Elevated Risk of Breast Cancer

Detection of Contralateral Malignancies on Breast MRI

Breast cancer survival following MRI detection in a high‐risk screening program

Magnetic resonance imaging of the breast: Could it be used as a screening test?

MRI is Not Exclusive for Breast Cancer Imaging Diagnostics

MRI can accurately diagnose breast cancer during lactation

New Trends of MRI in Breast Cancer Diagnosis

Contrast-enhanced mammography versus breast MRI in the assessment of multifocal and multicentric breast cancer: a retrospective study

Use of Contrast-Enhanced Mammography in Breast Cancer Screening

Diagnostic value of mammography combined with ultrasound shear wave elastography and magnetic resonance imaging in breast cancer

PET/MRI in Breast Cancer

Imaging surveillance for the detection of ipsilateral local tumor recurrence in patients who underwent oncoplastic breast-conserving surgery with acellular dermal matrix: abbreviated MRI versus conventional mammography and ultrasonography

Combined molybdenum target X-ray and magnetic resonance imaging examinations improve breast cancer diagnostic efficacy

MRI increases detection of prostate cancers and reduces overdiagnosis, finds study.

MR Imaging Evalution of Ductal Carcinoma in Situ and Ductal Carcinoma in Situ with Small Invasive Foci of Breast